Improvement in insulin secretion in diabetes after diazoxide (Q39368203)

11 September 2017

Improvement in insulin secretion in diabetes after diazoxide (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55717

9 April 2022

1 reference

R. H. Greenwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55717

9 April 2022

R. F. Mahler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55717

9 April 2022

C. N. Hales

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55717

9 April 2022

language of work or name

English

0 references

publication date

1 February 1976

1 reference

11 September 2017

28 February 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=55717

full work available at URL

9 April 2022

https://api.elsevier.com/content/article/PII:S0140673676914732?httpAccept=text/xml

1 reference

10.1016/S0140-6736(76)91473-2

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91473-2

https://api.elsevier.com/content/article/PII:S0140673676914732?httpAccept=text/plain

9 April 2022

1 reference

10.1016/S0140-6736(76)91473-2

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91473-2

9 April 2022

1 reference

11 September 2017

1

1 reference

11 September 2017

7957

1 reference

11 September 2017

444-447

1 reference

Immunoassay of endogenous plasma insulin in man

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, non-esterified fatty acid, and insulin during oral glucose-tolerance tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Plasma insulin in minor abnormalities of glucose tolerance: a 5 year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Sequential Changes in Beta-Cell Function in Insulin-Treated Diabetic Patients Assessed by C-Peptide Immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

EFFECT OF PROLONGED CARBOHYDRATE RESTRICTION ON SERUM-INSULIN LEVELS IN MILD DIABETES

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

AN ADRENERGIC MECHANISM FOR HYPERGLYCEMIA INDUCED BY DIAZOXIDE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

FAILURE OF PROLONGED SULFONYLUREA ADMINISTRATION TO ENHANCE INSULOGENIC RESPONSE TO GLYCEMIC STIMULUS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

The interaction of various inhibitors and stimuli of insulin release studied with rabbit pancreas in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Diazoxide blood levels in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Immunoassay of insulin with insulin-antibody precipitate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

The stimulus-secretion coupling of glucose-induced insulin release XII. Effects of diazoxide and gliclazide upon45calcium efflux from perifused islets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Studies of Insulin Secretion in the Perfused Rat Pancreas: Effect of Diazoxide and A025

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

The morphological substrate of the inhibition of insulin secretion by diazoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Insulin secretion studied in the perfused rat pancreas. II. Effect of glucose, glucagon, 3'5' adenosine monophosphate, theophylline, imidazole and phenoxybenzamine; their interaction with diazoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

The use of diazoxide inhibition of insulin secretion as a tool to investigate insulin stimulation by other agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Insulin I-131 disappearance rates following diazoxide, epinephrine and glucose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Dynamics of Tolbutamide, Glucose, and Insulin Interrelationships Following Varying Doses of Intravenous Tolbutamide in Normal Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

Inhibition of insulin secretion by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991473-2

7 January 2021

10.1016/S0140-6736(76)91473-2

Identifiers

DOI

1 reference

11 September 2017

1 reference